Name:
Heparin gel 1000IU/1g 30g
Description:
Colorless to light yellow gel with a specific odor. The main active ingredient Heparin sodium Product formGel Dosage 1000 U / 1g Pharmacological action Pharmacological studies show that when applied externally, Heparin gel has a pronounced anti-exudative, anti-edematous, anti-granulomatous, anti-inflammatory and anticoagulant effect. Indications for use – symptomatic treatment and reduction of edema and bruising after blunt trauma (for example, after a bruise); – symptomatic treatment of diseases of superficial veins (varicose veins, phlebitis, periphlebitis, thrombophlebitis), varicose ulcers, varicophlebitis, conditions after removal of the great saphenous vein as part of complex therapy. Method of application and doses 1-3 times a day, 3-10 cm of gel is applied to the affected area of the skin and gently rubbed. Due to the limited experience with the drug in children and due to the fact that there is an insufficient amount of research data, this drug should not be used in the treatment of children. Use during pregnancy and lactation Use during pregnancy is possible only if indicated under medical supervision. May be used during lactation according to indications. Influence on the ability to drive vehicles and other potentially dangerous mechanisms The drug does not affect the ability to drive vehicles and potentially dangerous mechanisms. Precautions If there are signs of bleeding, the possibility of using Heparin gel should be carefully considered. Gel Heparin should not be used for bleeding, applied to open wound surfaces, weeping eczema or mucous membranes, as well as to infected areas in the presence of purulent processes. The penetration of heparin into healthy skin is described in the case of topical application; therefore, if thromboembolic complications are suspected, a platelet count should be checked to differentiate between heparin-induced thrombocytopenia type II. Thus, regular checks of platelet counts in patients with a history of thromboembolic complications are necessary with each use of heparin (before starting heparin, on the first day after the start of use, and then regularly every 3-4 days during treatment until its end). Gel Heparin contains methyl parahydroxybenzoate and propyl parahydroxybenzoate as excipients, so it should not be used in patients allergic to parabens. Pediatric use Due to the limited experience of using the drug in children and due to the fact that there is an insufficient amount of research data, the gel should not be used in the treatment of children. Interaction with other drugs The anticoagulant effect of heparin is enhanced with the simultaneous use of anticoagulants, antiplatelet agents and non-steroidal anti-inflammatory drugs. Ergot alkaloids, thyroxine, tetracycline, antihistamines and nicotine reduce the effect of heparin. Contraindications – known hypersensitivity to heparin or any component of the drug; – heparin-induced thrombocytopenia type II (HIT type II, mediated by immunity) in history. One tube is composed of: active substance – heparin (in the form of sodium heparin) – 1000 IU / g; excipients – carbopol 980 NF, levomenthol, methyl parahydroxybenzoate (E-218), propyl parahydroxybenzoate (E-216), rectified ethyl alcohol from food raw materials, triethanolamine, purified water. Overdose Due to low systemic absorption, overdose is unlikely. So far, overdose phenomena when using Heparin gel have not been described. With prolonged use on large surfaces, hemorrhagic complications are possible. Treatment: drug withdrawal. If necessary, use a heparin antagonist – protamine sulfate (1% solution). Side effects Allergic reactions to heparin after applying the drug to the skin are very rare. However, in some cases, hypersensitivity reactions may occur, such as redness of the skin and itching, which quickly disappear after discontinuation of the drug. The incidence of heparin-induced antibody-mediated thrombocytopenia type II (platelet count <100,000/mcL or abrupt decrease in platelet count to <50% of baseline with arterial and venous thrombosis and embolism) has not been studied with topical heparin. However, since penetration into healthy skin has been described, this risk cannot be ruled out. In this regard, it is recommended to exercise extreme caution (see section "Precautions"). With parenteral heparin in patients without pre-existing hypersensitivity to heparin, a decrease in the number of platelets, as a rule, can occur 6-14 days after the start of treatment. In patients with hypersensitivity to heparin, thrombocytopenia may develop within a few hours. In case of adverse reactions, including those not listed in this leaflet, you should consult a doctor. Storage conditionsStore at a temperature not exceeding 25°C. Keep out of the reach of children. Buy Heparin gel i 1000me/g 30g №1 Price for Heparin gel i 1000me/g 30g №1
Heparin gel I 1000m/g 30g №1
$20.00
SKU: 26478
Category: Treatment and prevention of hemorrhoids and varicose veins
INN | HEPARIN |
---|---|
The code | 26 478 |
Barcode | 4 810 133 007 793 |
Dosage | 1000IU/g 30g |
Active substance | Heparin |
Manufacturer | Belmedpreparaty RUE, Belarus |
Be the first to review “Heparin gel I 1000m/g 30g №1” Cancel reply
Related products
Treatment and prevention of hemorrhoids and varicose veins
$14.00
Treatment and prevention of hemorrhoids and varicose veins
$18.00
Treatment and prevention of hemorrhoids and varicose veins
$20.00
Treatment and prevention of hemorrhoids and varicose veins
$8.00
Treatment and prevention of hemorrhoids and varicose veins
$24.00
Treatment and prevention of hemorrhoids and varicose veins
$14.00
Treatment and prevention of hemorrhoids and varicose veins
$18.00
Reviews
There are no reviews yet.